Escalating Need to Reduce Drug Development Costs and Time to Fuel AI Enabled Drug Discovery & Clinical Trials Market
A new study by MarkNtel Advisors, the Global AI Enabled Drug Discovery & Clinical Trials Market is likely to witness around 23.6% CAGR during 2021-26.
UNITED SATES, July 29, 2021 /EINPresswire.com/ It owes primarily to the rapidly increasing awareness regarding the benefits of AI among medical professionals, the mounting requirements to minimize the drug discovery cost & time, and burgeoning adoption of cloud-based services & applications, owing to which, faster, efficient, & cost-effective drug discovery, is gaining momentum amongst the pharmaceutical industry stakeholders.
Apart from this, delay in patent expiry and expansion of biotechnology industries are other crucial factors likely to enhance the market growth in the years to come.
Parexel Announces Innovative Patient Centric Partnership with Cancer Hospital Chinese Academy of Medical Sciences
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Companies Smashing the Psychedelic Ceiling
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GenesisCare extends U S brachytherapy service with 27 Elekta Flexitron treatment devices
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.